IN VITRO ANTIMICROBIAL SUSCEPTIBILITY AND TREATMENT OUTCOMES OF MOLECULAR DIAGNOSED MYCOBACTERIUM KANSASII PULMONARY DISEASE

被引：0
|
作者：
Liu, Chia-Jung [1 ]
Hsueh, Po-Ren [1 ,2 ]
Chien, Jung-Yien [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan
来源：
RESPIROLOGY | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO166
引用
收藏
页码：67 / 67
页数：1
相关论文
共 50 条
  • [1] Effect of cavity absorption on treatment outcomes of Mycobacterium kansasii pulmonary disease
    Zou, Xin
    Yi, Shulin
    Luo, Mengxing
    Zeng, Qibing
    Yao, Shixiu
    Chen, Lulu
    Yao, Xin
    Hu, Yang
    Liu, Zhonghua
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2025, 111 (04)
  • [2] Treatment of pulmonary disease caused by Mycobacterium kansasii
    Huang, Hung-Ling
    Lu, Po-Liang
    Lee, Chen-Hsiang
    Chong, Inn-Wen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2020, 119 : S51 - S57
  • [3] Antimicrobial susceptibility testing for Mycobacterium kansasii in Taiwan
    Wu, T. S.
    Lee, M. H.
    Leu, H. S.
    Wu, T. L.
    Chiang, P. C.
    Chiu, C. H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S303 - S303
  • [4] An overview of drugs for the treatment of Mycobacterium kansasii pulmonary disease
    Srivastava, Shashikant
    Pasipanodya, Jotam G.
    Heysell, Scott K.
    Boorgula, Gunavanthi D.
    Gumbo, Tawanda
    McShane, Pamela J.
    Philley, Julie, V
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 28 : 71 - 77
  • [5] Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease
    Bakula, Zofia
    Kosciuch, Justyna
    Safianowska, Aleksandra
    Proboszcz, Malgorzata
    Bielecki, Jacek
    van Ingen, Jakko
    Krenke, Rafal
    Jagielski, Tomasz
    RESPIRATORY MEDICINE, 2018, 139 : 91 - 100
  • [6] INITIAL TREATMENT IN MYCOBACTERIUM-KANSASII PULMONARY-DISEASE
    MONTANER, LJG
    ABBATE, EH
    BREA, A
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1983, 127 (04): : 202 - 202
  • [7] Pulmonary Mycobacterium kansasii disease in immunocompetent host: Treatment outcomes with short-course chemotherapy
    Padmapriyadarsini, C.
    Nair, D.
    Gomathi, N. S.
    Velayudham, B.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2016, 34 (04) : 516 - 519
  • [8] Drug susceptibility profiling of pulmonary Mycobacterium kansasii and its correlation with treatment outcome
    Rajendran, Priya
    Padmapriyadarsini, Chandrasekaran
    Vijayaraghavan, Vaishnavee
    Manoharan, Tamizhselvan
    Lokanathan, LakshanaMalla
    Kadhar, ParveenBanu
    Jayabal, Lavanya
    Sivaramakrishnan, Gomathy
    ANNALS OF THORACIC MEDICINE, 2021, 16 (04) : 323 - 328
  • [9] Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease
    Moon, Seong Mi
    Choe, Junsu
    Jhun, Byung Woo
    Jeon, Kyeongman
    Kwon, O. Jung
    Huh, Hee Jae
    Lee, Nam Yong
    Daley, Charles L.
    Koh, Won-Jung
    RESPIRATORY MEDICINE, 2019, 148 : 37 - 42
  • [10] Clinical Analysis of Pulmonary Mycobacterium kansasii Disease
    Kobashi, Yoshihiro
    Abe, Masaaki
    Yoshioka, Daisuke
    Kato, Shigeki
    Oga, Toru
    AMERICAN JOURNAL OF INFECTIOUS DISEASES, 2020, 16 (01) : 1 - 6
12345